Effect Of Virtual Reality On Pulmonary Function And Anxiety Levels In Asthmatic Patients
ConditionAsthma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-40
SponsorOctober 6 University
About this trial
The Purpose of the Study This study will be conducted to determine the effect of virtual reality on pulmonary function and anxiety levels in moderate to severe asthmatic patients.
Eligibility criteria
Qualifiers
Both sexes would be previously diagnosed as bronchial asthma with a cut-off score FEV1: Between 60% and 80% of predicted value or less than 60% of predicted value and FEV1/FVC ratio: May be significantly reduced from normal value 0.75-0.80.
The age of the patients will be ranged between 30 and 40 years old.
Asthma Control Test(ACT) will be less than 16 can be successfully used to identify those who will be uncontrolled asthma.
All patients will be assessed by Hospital Anxiety and Depression Scale (HADS) ;A cut-off score of 11-15 a moderate depression/anxiety level.
Disqualifiers
Previous participation in any pulmonary rehabilitation program.
Cardiovascular instabilities such as: Uncontrolled hypertension, Uncontrolled arrhythmia and Recent ischemic event.
Mental disorders preventing protocol implementation.
Other chronic respiratory diseases.
Trial design
Treatments tested in this trial
- Virtual reality glass
- Buteyko Breathing
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
October 6 university hospital outpatient chest department Status unavailable 12555, Giza, Cairo Governorate
Egypt
EgyptSponsors and collaborators
Source ClinicalTrials.gov